APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Albumin (Human)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Albumin (Human) Industry Growth and Trends Forecast to 2032

Report ID 173961580120 December 202590 pages

Choose your research edition.

Industry ResearchAlbumin (Human) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin (Human) Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Albumin (Human) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin (Human) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin (Human) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Albumin (Human) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Albumin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Albumin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albumin (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Albumin (Human) include CSL Behring, Grifols, Octapharma, Baxter, Hualan Bio, Shanghai Laishi, Taibang Bio and Zhongsheng Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Albumin (Human) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Albumin (Human) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Albumin (Human) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Albumin (Human).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Albumin (Human) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Albumin (Human) Market by Company

CSL Behring

Grifols

Octapharma

Baxter

Hualan Bio

Shanghai Laishi

Taibang Bio

Zhongsheng Group

Albumin (Human) Segment by Type

Injection

Freeze-dried Injection

Albumin (Human) Segment by Application

Liver Diseases

Kidney Diseases

Neoplasm

Other Diseases

Albumin (Human) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (Human).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albumin (Human) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Albumin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Freeze-dried Injection Table 3. Global Albumin (Human) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 5. Global Albumin (Human) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Albumin (Human) Sales Market Share in Value by Type (2021-2026) Table 8. Global Albumin (Human) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Albumin (Human) Sales by Type (2027-2032) & (K Units) Table 10. Global Albumin (Human) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Albumin (Human) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Albumin (Human) Sales Market Share in Value by Type (2027-2032) Table 13. Global Albumin (Human) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 15. North America Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 17. Europe Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Albumin (Human) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Albumin (Human) Sales by Type (2021-2026) & (US$ Million) Table 24. Albumin (Human) Industry Trends Table 25. Albumin (Human) Industry Drivers Table 26. Albumin (Human) Industry Opportunities and Challenges Table 27. Albumin (Human) Industry Restraints Table 28. Global Albumin (Human) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Albumin (Human) Revenue Market Share by Company (2021-2026) Table 30. Global Albumin (Human) Sales by Company (2021-2026) & (K Units) Table 31. Global Albumin (Human) Sales Share by Company (2021-2026) Table 32. Global Albumin (Human) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Albumin (Human) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Albumin (Human) Major Company Production Sites and Headquarters Table 35. Global Albumin (Human) Company, Product Type & Application Table 36. Global Albumin (Human) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Albumin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Albumin (Human) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Albumin (Human) Sales by Region (2021-2026) & (K Units) Table 41. Global Albumin (Human) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Albumin (Human) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Albumin (Human) Sales Market Share in Value by Region (2021-2026) Table 44. Global Albumin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Albumin (Human) Sales by Region (2027-2032) & (K Units) Table 46. Global Albumin (Human) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Albumin (Human) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Albumin (Human) Sales Market Share in Value by Region (2027-2032) Table 49. Global Albumin (Human) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Albumin (Human) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 52. Global Albumin (Human) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Albumin (Human) Sales Market Share in Value by Application (2021-2026) Table 55. Global Albumin (Human) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Albumin (Human) Sales by Application (2027-2032) & (K Units) Table 57. Global Albumin (Human) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Albumin (Human) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Albumin (Human) Sales Market Share in Value by Application (2027-2032) Table 60. Global Albumin (Human) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 62. North America Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 64. Europe Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Albumin (Human) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Albumin (Human) Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Behring Company Information Table 72. CSL Behring Business Overview Table 73. CSL Behring Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CSL Behring Albumin (Human) Product Portfolio Table 75. CSL Behring Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Grifols Albumin (Human) Product Portfolio Table 80. Grifols Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Octapharma Albumin (Human) Product Portfolio Table 85. Octapharma Recent Development Table 86. Baxter Company Information Table 87. Baxter Business Overview Table 88. Baxter Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Baxter Albumin (Human) Product Portfolio Table 90. Baxter Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hualan Bio Albumin (Human) Product Portfolio Table 95. Hualan Bio Recent Development Table 96. Shanghai Laishi Company Information Table 97. Shanghai Laishi Business Overview Table 98. Shanghai Laishi Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Laishi Albumin (Human) Product Portfolio Table 100. Shanghai Laishi Recent Development Table 101. Taibang Bio Company Information Table 102. Taibang Bio Business Overview Table 103. Taibang Bio Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Taibang Bio Albumin (Human) Product Portfolio Table 105. Taibang Bio Recent Development Table 106. Zhongsheng Group Company Information Table 107. Zhongsheng Group Business Overview Table 108. Zhongsheng Group Albumin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zhongsheng Group Albumin (Human) Product Portfolio Table 110. Zhongsheng Group Recent Development Table 111. North America Albumin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 113. North America Albumin (Human) Sales Market Share by Country (2021-2026) Table 114. North America Albumin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Albumin (Human) Sales Market Share Forecast by Country (2027-2032) Table 116. North America Albumin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Albumin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Albumin (Human) Market Share by Country (2021-2026) Table 119. North America Albumin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Albumin (Human) Market Share Forecast by Country (2027-2032) Table 121. Europe Albumin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 123. Europe Albumin (Human) Sales Market Share by Country (2021-2026) Table 124. Europe Albumin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Albumin (Human) Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Albumin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Albumin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Albumin (Human) Market Share by Country (2021-2026) Table 129. Europe Albumin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Albumin (Human) Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Albumin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Albumin (Human) Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Albumin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Albumin (Human) Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Albumin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Albumin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Albumin (Human) Market Share by Country (2021-2026) Table 139. Asia-Pacific Albumin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Albumin (Human) Market Share Forecast by Country (2027-2032) Table 141. Latin America Albumin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 143. Latin America Albumin (Human) Sales Market Share by Country (2021-2026) Table 144. Latin America Albumin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Albumin (Human) Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Albumin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Albumin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Albumin (Human) Market Share by Country (2021-2026) Table 149. Latin America Albumin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Albumin (Human) Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Albumin (Human) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Albumin (Human) Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Albumin (Human) Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Albumin (Human) Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Albumin (Human) Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Albumin (Human) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Albumin (Human) Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Albumin (Human) Market Share by Country (2021-2026) Table 159. Middle East and Africa Albumin (Human) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Albumin (Human) Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Albumin (Human) Distributors List Table 164. Albumin (Human) Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Albumin (Human) Image Figure 2. Global Albumin (Human) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin (Human) Market Size (2021-2032) & (US$ Million) Figure 4. Global Albumin (Human) Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Freeze-dried Injection Image Figure 8. Global Freeze-dried Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Albumin (Human) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Albumin (Human) Market Share by Type 2025 VS 2032 Figure 11. North America Albumin (Human) Sales Market Share in Volume by Type in 2025 Figure 12. North America Albumin (Human) Sales Market Share in Value by Type in 2025 Figure 13. Europe Albumin (Human) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Albumin (Human) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Albumin (Human) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Albumin (Human) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Albumin (Human) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Albumin (Human) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Albumin (Human) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Albumin (Human) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Albumin (Human) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Liver Diseases Image Figure 24. Global Liver Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 25. Kidney Diseases Image Figure 26. Global Kidney Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 27. Neoplasm Image Figure 28. Global Neoplasm Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Diseases Image Figure 30. Global Other Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Albumin (Human) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Albumin (Human) Market Share by Application 2025 VS 2032 Figure 33. North America Albumin (Human) Sales Market Share in Volume by Application in 2025 Figure 34. North America Albumin (Human) Sales Market Share in Value by Application in 2025 Figure 35. Europe Albumin (Human) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Albumin (Human) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Albumin (Human) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Albumin (Human) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Albumin (Human) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Albumin (Human) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Albumin (Human) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Albumin (Human) Sales Market Share in Value by Application in 2025 Figure 43. North America Albumin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Albumin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Albumin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Albumin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Albumin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Albumin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Albumin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Albumin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Albumin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Albumin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Albumin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Albumin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Albumin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Albumin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Albumin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Albumin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Albumin (Human) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Albumin (Human) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Albumin (Human) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Albumin (Human) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Albumin (Human) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Albumin (Human) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-dried Injection
Applications
  • Liver Diseases
  • Kidney Diseases
  • Neoplasm
  • Other Diseases
Companies covered
  • CSL Behring
  • Grifols
  • Octapharma
  • Baxter
  • Hualan Bio
  • Shanghai Laishi
  • Taibang Bio
  • Zhongsheng Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albumin (Human) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Albumin (Human) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Albumin (Human) Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Freeze-dried Injection
  8. 1.4 Global Albumin (Human) Market Size by Type
  9. 1.4.1 Global Albumin (Human) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Albumin (Human) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Albumin (Human) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Albumin (Human) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Albumin (Human) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Albumin (Human) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Albumin (Human) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Albumin (Human) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Albumin (Human) Industry Trends
  2. 2.2 Albumin (Human) Industry Drivers
  3. 2.3 Albumin (Human) Industry Opportunities and Challenges
  4. 2.4 Albumin (Human) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Albumin (Human) Revenue (2021-2026)
  2. 3.2 Global Top Players by Albumin (Human) Sales (2021-2026)
  3. 3.3 Global Top Players by Albumin (Human) Price (2021-2026)
  4. 3.4 Global Albumin (Human) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albumin (Human) Major Company Production Sites & Headquarters
  6. 3.6 Global Albumin (Human) Company, Product Type & Application
  7. 3.7 Global Albumin (Human) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albumin (Human) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albumin (Human) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albumin (Human) Tier 1, Tier 2, and Tier 3
4 Albumin (Human) Regional Status and Outlook
  1. 4.1 Global Albumin (Human) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Albumin (Human) Historic Market Size by Region
  3. 4.2.1 Global Albumin (Human) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Albumin (Human) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Albumin (Human) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Albumin (Human) Forecasted Market Size by Region
  7. 4.3.1 Global Albumin (Human) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Albumin (Human) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Albumin (Human) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Albumin (Human) by Application
  1. 5.1 Albumin (Human) Market by Application
  2. 5.1.1 Liver Diseases
  3. 5.1.2 Kidney Diseases
  4. 5.1.3 Neoplasm
  5. 5.1.4 Other Diseases
  6. 5.2 Global Albumin (Human) Market Size by Application
  7. 5.2.1 Global Albumin (Human) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Albumin (Human) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Albumin (Human) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Albumin (Human) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Albumin (Human) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Albumin (Human) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Albumin (Human) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Albumin (Human) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Behring Albumin (Human) Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Albumin (Human) Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 Octapharma
  14. 6.3.1 Octapharma Company Information
  15. 6.3.2 Octapharma Business Overview
  16. 6.3.3 Octapharma Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Octapharma Albumin (Human) Product Portfolio
  18. 6.3.5 Octapharma Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Albumin (Human) Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Hualan Bio
  26. 6.5.1 Hualan Bio Company Information
  27. 6.5.2 Hualan Bio Business Overview
  28. 6.5.3 Hualan Bio Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Bio Albumin (Human) Product Portfolio
  30. 6.5.5 Hualan Bio Recent Developments
  31. 6.6 Shanghai Laishi
  32. 6.6.1 Shanghai Laishi Company Information
  33. 6.6.2 Shanghai Laishi Business Overview
  34. 6.6.3 Shanghai Laishi Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Laishi Albumin (Human) Product Portfolio
  36. 6.6.5 Shanghai Laishi Recent Developments
  37. 6.7 Taibang Bio
  38. 6.7.1 Taibang Bio Company Information
  39. 6.7.2 Taibang Bio Business Overview
  40. 6.7.3 Taibang Bio Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taibang Bio Albumin (Human) Product Portfolio
  42. 6.7.5 Taibang Bio Recent Developments
  43. 6.8 Zhongsheng Group
  44. 6.8.1 Zhongsheng Group Company Information
  45. 6.8.2 Zhongsheng Group Business Overview
  46. 6.8.3 Zhongsheng Group Albumin (Human) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zhongsheng Group Albumin (Human) Product Portfolio
  48. 6.8.5 Zhongsheng Group Recent Developments
7 North America by Country
  1. 7.1 North America Albumin (Human) Sales by Country
  2. 7.1.1 North America Albumin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Albumin (Human) Sales by Country (2021-2026)
  4. 7.1.3 North America Albumin (Human) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Albumin (Human) Market Size by Country
  6. 7.2.1 North America Albumin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Albumin (Human) Market Size by Country (2021-2026)
  8. 7.2.3 North America Albumin (Human) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Albumin (Human) Sales by Country
  2. 8.1.1 Europe Albumin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Albumin (Human) Sales by Country (2021-2026)
  4. 8.1.3 Europe Albumin (Human) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Albumin (Human) Market Size by Country
  6. 8.2.1 Europe Albumin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Albumin (Human) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Albumin (Human) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Albumin (Human) Sales by Country
  2. 9.1.1 Asia-Pacific Albumin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Albumin (Human) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Albumin (Human) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Albumin (Human) Market Size by Country
  6. 9.2.1 Asia-Pacific Albumin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Albumin (Human) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Albumin (Human) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Albumin (Human) Sales by Country
  2. 10.1.1 South America Albumin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Albumin (Human) Sales by Country (2021-2026)
  4. 10.1.3 South America Albumin (Human) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Albumin (Human) Market Size by Country
  6. 10.2.1 South America Albumin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Albumin (Human) Market Size by Country (2021-2026)
  8. 10.2.3 South America Albumin (Human) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Albumin (Human) Sales by Country
  2. 11.1.1 Middle East and Africa Albumin (Human) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Albumin (Human) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Albumin (Human) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Albumin (Human) Market Size by Country
  6. 11.2.1 Middle East and Africa Albumin (Human) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Albumin (Human) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Albumin (Human) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Albumin (Human) Value Chain Analysis
  2. 12.1.1 Albumin (Human) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Albumin (Human) Production Mode & Process
  7. 12.2 Albumin (Human) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Albumin (Human) Distributors
  10. 12.2.3 Albumin (Human) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst